Literature DB >> 19304003

Protocols, probity, and publication.

William Summerskill1, David Collingridge, Helen Frankish.   

Abstract

Mesh：

Year:  2009        PMID： 19304003     DOI： 10.1016/S0140-6736(09)60590-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

2.  Informed consent: time for more transparency.

Authors:  Yusuf Yazici; Hasan Yazici
Journal:  Arthritis Res Ther       Date:  2010-06-03       Impact factor: 5.156

3.  SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krle A-Jerić; Asbjørn Hrobjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Dore; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Rev Panam Salud Publica       Date:  2015-12

4.  Comparisons between protocols and publications of case-control studies: analysis of potential causes of non-reproducibility and recommendations for enhancing the quality of personalization in healthcare.

Authors:  Haifeng Hou; Guoyong Ding; Xuan Zhao; Zixiu Meng; Jiangmin Xu; Zheng Guo; Yulu Zheng; Dong Li; Wei Wang
Journal:  EPMA J       Date:  2019-03-19       Impact factor: 6.543

5.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

6.  Publishing protocols for trials of complex interventions before trial completion - potential pitfalls, solutions and the need for public debate.

Authors:  Anna Purna Basu; Janice Elizabeth Pearse; Tim Rapley
Journal:  Trials       Date:  2017-01-09       Impact factor: 2.279

7.  Review and publication of protocol submissions to Trials - what have we learned in 10 years?

Authors:  Tianjing Li; Isabelle Boutron; Rustam Al-Shahi Salman; Erik Cobo; Ella Flemyng; Jeremy M Grimshaw; Douglas G Altman
Journal:  Trials       Date:  2016-12-16       Impact factor: 2.279

8.  Comparison of primary endpoints between publications, registries, and protocols of phase III cancer clinical trials.

Authors:  Fei Liang; Xinmei Guo; Sheng Zhang; Hongxi Xue; Qiang Chen; Xichun Hu
Journal:  Oncotarget       Date:  2017-10-03

9.  A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan.

Authors:  Rebecca Walwyn; Laura Potts; Paul McCrone; Anthony L Johnson; Julia C DeCesare; Hannah Baber; Kimberley Goldsmith; Michael Sharpe; Trudie Chalder; Peter D White
Journal:  Trials       Date:  2013-11-13       Impact factor: 2.279
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.